Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Egypharma, officially known as the Egyptian Pharmaceutical and Chemical Industries (EPCI), is a leading pharmaceutical manufacturer based in Obour City, Egypt. Established in 1991, the company has developed a robust portfolio of generic pharmaceutical products across diverse therapeutic areas, including cardiology, gastroenterology, neurology, and musculoskeletal health. Egypharma operates high-tech manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards, allowing it to serve both the domestic Egyptian market and over 30 export markets across the Middle East and Africa. In addition to its own branded generics, the company is a significant provider of contract manufacturing services for several multinational pharmaceutical corporations. Through its commitment to quality and affordability, Egypharma has become one of the fastest-growing healthcare entities in the MENA region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Egypharma.